| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 353 |
| 1 | ATORVASTATIN CALCIUM, FILM COATED | 342 |
| 2 | NIVOLUMAB | 248 |
| 3 | METFORMIN | 237 |
| 4 | METFORMIN ER 500 MG | 237 |
| 5 | METFORMIN ER 750 MG | 237 |
| 6 | SIMVASTATIN | 183 |
| 7 | METHOTREXATE SODIUM | 166 |
| 8 | ASPIRIN | 162 |
| 9 | ASPIRIN 325 MG | 161 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENSITRELVIR | 1 | 0.0556 |
| 1 | ATORVALIQ | 1 | 0.0476 |
| 2 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 16 | 0.0435 |
| 3 | ANTACID TABLETS | 1 | 0.0303 |
| 4 | TELMISARTAN AND AMLODIPINE | 3 | 0.0300 |
| 5 | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | 1 | 0.0244 |
| 6 | ADENINE | 1 | 0.0204 |
| 7 | NIVOLUMAB AND RELATLIMAB-RMBW | 9 | 0.0175 |
| 8 | VARDENAFIL | 8 | 0.0134 |
| 9 | PENPULIMAB | 1 | 0.0102 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 9 | 0.0175 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 157 | 0.0033 |
| 2 | Human Immunoglobulin G [EPC] | 63 | 0.0030 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 61 | 0.0028 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 257 | 0.0026 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Blood Viscosity Reducer [EPC] | 5 | 0.0012 |
| 7 | Dietary Cholesterol Absorption Inhibitor [EPC] | 103 | 0.0011 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 33 | 0.0010 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 323 | 0.0009 |